CD53 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD53 monoclonal antibodies for research focused on understanding CD53 protein functions. CD53 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD53 is a transmembrane glycoprotein that plays a critical role in immune cell activation and signaling. CD53 actively participates in the regulation of leukocyte adhesion and migration, making it essential for proper immune responses. Understanding CD53 function is vital for elucidating its contributions to immune system disorders and potential therapeutic targets. CD53 research has revealed significant implications in various immune-related conditions and diseases. Ongoing studies continue to uncover new aspects of CD53's role in cellular communication and immune regulation. Research utilizing CD53 monoclonal antibodies has enhanced our understanding of immune system mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific knowledge in immunology and cell biology.